HomeAI · summaries
Storia in 3 fonti
Natco Pharma gets USFDA nod for generic cancer drug, shares rise 4% intra-day
Natco Pharma receives USFDA approval for generic Olaparib tablets, partnering with Alembic Pharmaceuticals for distribution in the U.S.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bn
Alembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug, which is a generic equivalent of…
- ·
thehindubusinessline.com
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
